Labour Induction With Misoprostol, Dinoprostone and Bard Catheter

NCT ID: NCT00602095

Last Updated: 2008-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

592 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-12-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomised study aimed at comparing the currently most frequently used prostaglandin dinoprostone to two other methods, the cheaper and perhaps more effective prostaglandin misoprostol and a transcervical catheter. 592 women were recruited and randomised to one of the three methods. The main outcome measures were time to delivery, rate of instrumental deliveries and maternal neonatal outcome. Our hypothesis was that misoprostol would be superior to the other methods.

The main finding of our trial was that the catheter showed the shortest induction to delivery interval. There were no differences between the two other prostaglandins. No differences in maternal and neonatal outcome was found

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Labour induction with misoprostol

Group Type EXPERIMENTAL

misoprostol

Intervention Type DRUG

0.025mg tablet vaginally every 4 hour until progress

2

Labour induction with dinoprostone

Group Type ACTIVE_COMPARATOR

dinoprostone

Intervention Type DRUG

2mg vaginal gel every 6 hours until progress

3

Labour induction with bard

Group Type EXPERIMENTAL

Bard Catheter (balloon catheter)

Intervention Type DEVICE

Intracervical balloon catheter positioned above internal cervical os and filled with sterile water. Removed when cervix was dilated

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

misoprostol

0.025mg tablet vaginally every 4 hour until progress

Intervention Type DRUG

dinoprostone

2mg vaginal gel every 6 hours until progress

Intervention Type DRUG

Bard Catheter (balloon catheter)

Intracervical balloon catheter positioned above internal cervical os and filled with sterile water. Removed when cervix was dilated

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cytotec, one quarter of a 0.100mg tablet Minprostin Bard Catheter

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Full term singleton pregnancy with vertex presentation and with an indication for labour induction.
* Absence of active labour
* Bishop score ≤ 6.
* Normal CTG registration

Exclusion Criteria

* Previous cesarean section
* signs of infection
* immediate need for delivery
* any contraindication for vaginal delivery
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karolinska University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Karolinska University Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lena Marions, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Karolinska University Hospital Institute

References

Explore related publications, articles, or registry entries linked to this study.

de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.

Reference Type DERIVED
PMID: 36996264 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KS2007

Identifier Type: -

Identifier Source: secondary_id

LMS2007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Different Medications to Induce Labor
NCT06259097 RECRUITING PHASE3